This Article Full Text Full Text (PDF) All Versions of this Article: 2007-0197OCv1 38/2/176    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vij, N. Articles by Zeitlin, P. L. Search for Related Content PubMed PubMed Citation Articles by Vij, N. Articles by Zeitlin, P. L.

CHOP Transcription Factor Mediates IL-8 Signaling in Cystic Fibrosis Bronchial Epithelial Cells

¹ Division of Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland

Correspondence and requests for reprints should be addressed to Pamela L. Zeitlin, Professor of Pediatrics, Division of Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, 200 N. Wolfe St., Baltimore, MD 21287. E-mail: pzeitlin{at}jhmi.edu

Interleukin (IL)-8 is a potent neutrophil chemoattractant that drives the inflammatory response in cystic fibrosis (CF). Traditional approaches to the pathophysiology of this inflammation have focused on targeting NF-B–dependent signaling and therapy with glucocorticoids. We test the hypothesis that an alternative pathway, independent of NF-B, operates through prostaglandin E2 (PGE-2) receptor EP-2 and stimulates IL-8 chemokine secretion. Using CF bronchial epithelial cells (IB3-1) in vitro, exogenous PGE-2 induces IL-8 release in a dose-dependent manner. These events are associated with elevation in the EP-2 receptors. Inhibition of cyclooxygenase (Cox)-2 with NS-398 was associated with reductions in Cox-2 (2-fold) and IL-6 (1.3-fold) mRNA transcripts, and in IL-8 and PGE-2 chemokine secretion. The inhibition of Cox-2 signaling led to down-regulation of the downstream C/EBP homologous protein (CHOP) transcription factor, resulting in a decrease in IL-8 activation. We confirmed the regulation of IL-8 promoter by CHOP in CF cells using the IL-8 reporter assay. We conclude that PGE-2 stimulates IL-8 production through the CHOP transcription factor in CF cells.

Key Words: PGE-2 • chemokine • cAMP • ibuprofen • CFTR

CLINICAL RELEVANCE IL-8 drives the inflammatory response in cystic fibrosis (CF). We show an alternative, non–NF-B, signaling pathway for prostaglandin E2–induced IL-8 stimulation in CF. We provide additional data regarding the potential of cyclooxygenase-2 inhibition for CF lung disease.

 

This article has been cited by other articles:

				M. Cucinotta, M. Visalli, M. Aguennouz, A. Valenti, S. Loddo, L. Altucci, and D. Teti Regulation of Interleukin-8 Gene at a Distinct Site of Its Promoter by CCAAT Enhancer-binding Protein Homologous Protein in Prostaglandin E2-treated Human T Cells J. Biol. Chem., October 31, 2008; 283(44): 29760 - 29769. [Abstract] [Full Text] [PDF]

				T. Roque, E. Boncoeur, V. Saint-Criq, E. Bonvin, A. Clement, O. Tabary, and J. Jacquot Proinflammatory Effect of Sodium 4-Phenylbutyrate in {Delta}F508-Cystic Fibrosis Transmembrane Conductance Regulator Lung Epithelial Cells: Involvement of Extracellular Signal-Regulated Protein Kinase 1/2 and c-Jun-NH2-Terminal Kinase Signaling J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 949 - 956. [Abstract] [Full Text] [PDF]

				C. J. Blohmke, R. E. Victor, A. F. Hirschfeld, I. M. Elias, D. G. Hancock, C. R. Lane, A. G. F. Davidson, P. G. Wilcox, K. D. Smith, J. Overhage, et al. Innate Immunity Mediated by TLR5 as a Novel Antiinflammatory Target for Cystic Fibrosis Lung Disease J. Immunol., June 1, 2008; 180(11): 7764 - 7773. [Abstract] [Full Text] [PDF]